Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Awdishu

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Current Opinion in Critical Care|September 28, 2017
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategiesLinda Awdishu
Seminars in Dialysis|April 27, 2011
How to optimize drug delivery in renal replacement therapyLinda Awdishu, Josée Bouchard
Nephron|September 11, 2022
Drug-Induced Acute Kidney Injury Risk Prediction ModelsZaid Yousif, Linda Awdishu
Kidney360|August 3, 2022
Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: PROLinda Awdishu, Ruben Abagyan
BMC Nephrology|April 5, 2017
The 6R's of drug induced nephrotoxicityLinda Awdishu, Ravindra L Mehta
Seminars in Immunopathology|February 19, 2011
Steroids in kidney transplant patientsRobert W Steiner, Linda Awdishu
Advances in Chronic Kidney Disease|March 17, 2016
Role of Pharmacogenomics in Kidney Disease and InjuryLinda Awdishu, Melanie S Joy
Seminars in Dialysis|May 3, 2021
Drug dosing considerations in continuous renal replacement therapySoo Min Jang, Linda Awdishu
Kidney International Reports|August 13, 2021
A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement TherapyRima H Bouajram, Linda Awdishu
Kidney360|May 25, 2023
Endocytosis and Nephrotoxicity-It's a RAP!Linda Awdishu, Melanie S Joy
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Current Opinion in Critical Care|September 28, 2017
Drug-induced kidney disease in the ICU: mechanisms, susceptibility, diagnosis and management strategiesLinda Awdishu
Seminars in Dialysis|April 27, 2011
How to optimize drug delivery in renal replacement therapyLinda Awdishu, Josée Bouchard
Nephron|September 11, 2022
Drug-Induced Acute Kidney Injury Risk Prediction ModelsZaid Yousif, Linda Awdishu
Kidney360|August 3, 2022
Do Proton-Pump Inhibitors Cause CKD and Progression of CKD?: PROLinda Awdishu, Ruben Abagyan
BMC Nephrology|April 5, 2017
The 6R's of drug induced nephrotoxicityLinda Awdishu, Ravindra L Mehta
Seminars in Immunopathology|February 19, 2011
Steroids in kidney transplant patientsRobert W Steiner, Linda Awdishu
Advances in Chronic Kidney Disease|March 17, 2016
Role of Pharmacogenomics in Kidney Disease and InjuryLinda Awdishu, Melanie S Joy
Seminars in Dialysis|May 3, 2021
Drug dosing considerations in continuous renal replacement therapySoo Min Jang, Linda Awdishu
Kidney International Reports|August 13, 2021
A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement TherapyRima H Bouajram, Linda Awdishu
Kidney360|May 25, 2023
Endocytosis and Nephrotoxicity-It's a RAP!Linda Awdishu, Melanie S Joy
Pageof 7